• Latest Posts

A gene editing milestone: The FDA approves CASGEVY, the first CRISPR-based therapy

In Depth 19 Jun 2023

Gene therapy: a promising solution for sickle cell disease

Milestone for gene-edited therapy for sickle cell disease

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

In Depth 22 Nov 2021

How Will We Be Treating Cystic Fibrosis 10 Years From Now?


CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

Vertex Partners Oxford Genome Analysis Firm To Develop New Personalized Therapies

CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018

Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug

More News! 2 Feb 2017

Galapagos kicks off a Phase IIa trial for Cystic Fibrosis